{
    "organizations": [],
    "uuid": "0a8d5c9660e2b966d167772be40cdd56eb028264",
    "author": "",
    "url": "https://www.reuters.com/article/brief-akcea-completes-enrollment-in-phas/brief-akcea-completes-enrollment-in-phase-2b-study-of-akcea-apo-lrx-idUSFWN1PX118",
    "ord_in_thread": 0,
    "title": "BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 7, 2018 / 12:09 PM / in 9 minutes BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx Reuters Staff 1 Min Read \nFeb 7 (Reuters) - Akcea Therapeutics Inc: \n* AKCEA COMPLETES ENROLLMENT IN PHASE 2B STUDY OF AKCEA-APO(A)-LRX Source text for Eikon: Further company coverage:",
    "published": "2018-02-07T14:08:00.000+02:00",
    "crawled": "2018-02-07T14:21:20.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "completes",
        "enrollment",
        "phase",
        "2b",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "akcea",
        "therapeutic",
        "inc",
        "akcea",
        "completes",
        "enrollment",
        "phase",
        "2b",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}